Your shopping cart is currently empty

LP-03 is an antibacterial agent that exhibits selective activity against methicillin-resistant Staphylococcus aureus (MRSA) with a minimum inhibitory concentration (MIC) of 6.2 μM. It inhibits biofilm formation but is ineffective at removing established biofilms. LP-03 enhances membrane permeability, disrupting the membrane structure of MRSA cells without causing significant membrane depolarization. It shows no hemolytic toxicity and demonstrates low cytotoxicity to mammalian cells. This compound can be utilized for studying MRSA infections.
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | Inquiry | Inquiry | |
| 50 mg | Inquiry | Inquiry | Inquiry |
| Description | LP-03 is an antibacterial agent that exhibits selective activity against methicillin-resistant Staphylococcus aureus (MRSA) with a minimum inhibitory concentration (MIC) of 6.2 μM. It inhibits biofilm formation but is ineffective at removing established biofilms. LP-03 enhances membrane permeability, disrupting the membrane structure of MRSA cells without causing significant membrane depolarization. It shows no hemolytic toxicity and demonstrates low cytotoxicity to mammalian cells. This compound can be utilized for studying MRSA infections. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
Dissolve 2 mg of the compound in 100 μL DMSO
to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.
1) Add 100 μL of the DMSO
stock solution to 400 μL PEG300
and mix thoroughly until the solution becomes clear.
2) Add 50 μL Tween 80 and mix well until fully clarified.
3) Add 450 μL Saline,PBS or ddH2O
and mix thoroughly until a homogeneous solution is obtained.
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.